These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 32227556)

  • 61. Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure.
    Habal MV; Liu PP; Austin PC; Ross HJ; Newton GE; Wang X; Tu JV; Lee DS
    Circ Heart Fail; 2014 Jan; 7(1):12-20. PubMed ID: 24297690
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF) Trial.
    Abualnaja S; Podder M; Hernandez AF; McMurray JJ; Starling RC; O'Connor CM; Califf RM; Armstrong PW; Ezekowitz JA
    J Am Heart Assoc; 2015 Aug; 4(8):e002092. PubMed ID: 26304935
    [TBL] [Abstract][Full Text] [Related]  

  • 63. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
    Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF).
    Kelly JP; Mentz RJ; Hasselblad V; Ezekowitz JA; Armstrong PW; Zannad F; Felker GM; Califf RM; O'Connor CM; Hernandez AF
    Am Heart J; 2015 Aug; 170(2):298-305. PubMed ID: 26299227
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction.
    Kajimoto K; Minami Y; Sato N; Kasanuki H;
    Am J Cardiol; 2016 Dec; 118(12):1881-1887. PubMed ID: 27720439
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.
    Zafrir B; Salman N; Crespo-Leiro MG; Anker SD; Coats AJ; Ferrari R; Filippatos G; Maggioni AP; Mebazaa A; Piepoli MF; Ruschitzka F; Paniagua-Martin MJ; Segovia J; Laroche C; Amir O;
    Eur J Heart Fail; 2016 Jul; 18(7):859-68. PubMed ID: 27198159
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sex-Specific Prevalence, Incidence, and Mortality Associated With Atrial Fibrillation in Heart Failure.
    Barillas-Lara MI; Monahan K; Helm RH; Vasan RS; Schou M; Køber L; Gislason G; Torp-Pedersen C; Andersson C
    JACC Clin Electrophysiol; 2021 Nov; 7(11):1366-1375. PubMed ID: 33933409
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Heart failure hospitalization: An important prognostic factor for heart failure re-admission and mortality.
    Ruigómez A; Michel A; Martín-Pérez M; García Rodríguez LA
    Int J Cardiol; 2016 Oct; 220():855-61. PubMed ID: 27400184
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence, Determinants, and Prognostic Significance of Pulmonary Hypertension in Elderly Patients Admitted with Acute Decompensated Heart Failure: A Report from the BIO-HF Registry.
    Vanhercke D; Pardaens S; Weytjens C; Vande Kerckhove B; De Laet N; Janssens E; Van Camp G; De Sutter J
    Echocardiography; 2015 Sep; 32(9):1333-8. PubMed ID: 25470753
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Psoriasis and risk of heart failure: a nationwide cohort study.
    Khalid U; Ahlehoff O; Gislason GH; Kristensen SL; Skov L; Torp-Pedersen C; Hansen PR
    Eur J Heart Fail; 2014 Jul; 16(7):743-8. PubMed ID: 24903077
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction.
    Jobs A; Schwind J; Katalinic A; Babaev V; Tilz RR; Rausch S; Thiele H; Eitel I; Eitel C
    Clin Res Cardiol; 2019 Jan; 108(1):74-82. PubMed ID: 29987595
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.
    Girerd N; Pang PS; Swedberg K; Fought A; Kwasny MJ; Subacius H; Konstam MA; Maggioni A; Gheorghiade M; Zannad F;
    Eur J Heart Fail; 2013 Nov; 15(11):1228-35. PubMed ID: 23787720
    [TBL] [Abstract][Full Text] [Related]  

  • 73. De novo acute heart failure: Clinical features and one-year mortality in the Spanish nationwide Registry of Acute Heart Failure.
    Franco J; Formiga F; Corbella X; Conde-Martel A; Llácer P; Álvarez Rocha P; Ormaechea Gorricho G; Satué J; Soler Rangel L; Manzano L; Montero-Pérez-Barquero M; ;
    Med Clin (Barc); 2019 Feb; 152(4):127-134. PubMed ID: 30712652
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Discharge disposition and 1-year readmission in acute-phase hospitalized patients with heart failure: a retrospective observational multi-center study.
    Kato M; Mori Y; Watanabe D; Onoda H; Fujiyama K; Toda M; Kito K
    Heart Vessels; 2022 Sep; 37(9):1551-1561. PubMed ID: 35391584
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Lip GY
    Eur J Heart Fail; 2013 Apr; 15(4):415-24. PubMed ID: 23302606
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Temporal Relationship between Atrial Fibrillation and Heart Failure Development Analysis from a Nationwide Database.
    Cottin Y; Maalem Ben Messaoud B; Monin A; Guilleminot P; Bisson A; Eicher JC; Bodin A; Herbert J; Juillière Y; Zeller M; Fauchier L
    J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768619
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Atrial fibrillation burden and subsequent heart failure events in patients with cardiac resynchronization therapy devices.
    Tanawuttiwat T; Lande J; Smeets P; Gerritse B; Nazarian S; Guallar E; Cheng A
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1519-1526. PubMed ID: 32162753
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial.
    Khan H; Greene SJ; Fonarow GC; Kalogeropoulos AP; Ambrosy AP; Maggioni AP; Zannad F; Konstam MA; Swedberg K; Yancy CW; Gheorghiade M; Butler J;
    Eur J Heart Fail; 2015 Oct; 17(10):1022-31. PubMed ID: 25960401
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure.
    Masson S; Batkai S; Beermann J; Bär C; Pfanne A; Thum S; Magnoli M; Balconi G; Nicolosi GL; Tavazzi L; Latini R; Thum T
    Eur J Heart Fail; 2018 Jan; 20(1):78-85. PubMed ID: 29027324
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Relation of Acute Heart Failure Hospital Length of Stay to Subsequent Readmission and All-Cause Mortality.
    Reynolds K; Butler MG; Kimes TM; Rosales AG; Chan W; Nichols GA
    Am J Cardiol; 2015 Aug; 116(3):400-5. PubMed ID: 26037295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.